One local therapy dog is making a big difference for veterans across the Tampa Bay Area. He spends his days working with the spinal cord injury unit at the James A. Haley Veteran’s Hospital. In 2025, ...
A paw-sible path to a longer life? About 43% of US households — especially those run by millennials — own a pooch. Research has long suggested that there are numerous physical and mental benefits to ...
Flea and tick medications trusted by pet owners worldwide may have an unexpected environmental cost. Scientists found that active ingredients from isoxazoline treatments pass into pet feces, exposing ...
Two rescued Westies have found their forever home in time for National Love Your Pet Day. Did you know with an ad-lite subscription to Farming Life, you get 70% fewer ads while viewing the news that ...
The animal-loving team at Ginger Cat showcases dogs creating heart-melting, funny moments that tug at your emotions. Warning issued as millions told don't drink coffee McDonald’s newest $3 value menu ...
Dr. Tom Walsh, DVM, CCAT, CCRP, MBA, had a successful career in telecommunications but always knew his true calling was helping animals. Deciding to pursue that passion, he became a veterinarian and ...
Nelly, a 7-year-old dog, ingested three kinds of human medications before her heart stopped Rachel Raposas is a writer-reporter at PEOPLE, and has been working at PEOPLE since 2024. Kelli Bender is ...
Shyam Bansal receives funding from the National Heart, Lung and Blood Institute of the National Institutes of Health, the American Heart Association and the W.W. Smith Charitable Trust. He is a member ...
Jan 19 (Reuters) - Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable tablet, as the first drug to delay congestive heart ...
NASHVILLE, Tenn. (WSMV) - A Nashville pup has finally found his fur-ever home after a more than 200-day-long stay at a shelter. A family from Las Vegas has adopted Vinny from the Nashville Humane ...
Panelists discuss how SGLT2 inhibitors evolved from diabetes medications to become foundational heart failure therapy with class I recommendations across the ejection fraction spectrum, providing ...